HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: Implications for public health intervention

被引:542
作者
Clements-Nolle, K
Marx, R
Guzman, R
Katz, M
机构
[1] Dept Publ Hlth, Epidemiol & Evaluat Sect, San Francisco, CA 94102 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
D O I
10.2105/AJPH.91.6.915
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. This study described HIV prevalence, risk behaviors, health care use, and mental health status of male-to-female and female-to-male transgender persons and determined factors associated with HIV. Methods. We recruited transgender persons through targeted sampling, respondent-driven sampling, and agency 392 male-to-female and 123 female-to-male transgender persons were interviewed and tested for HIV. Results. HIV prevalence among male-to-female transgender persons was 35%. African American race (adjusted odds ratio [OR] = 5.81; 95% confidence interval [CI] = 2.82, 11.96), a history of injection drug use (OR = 2.69; 95% CI = 1.56, 4.62), multiple sex partners (adjusted OR = 2.64; 95% CI = 1.50,4.62), and low education (adjusted OR = 2.08; 95% CI = 1.17, 3.68) were independently associated with HIV Among female-to-male transgender persons, HIV prevalence (2%) and risk behaviors were much lower. Most male-to-female (78%) and female-to-male (83%) transgender persons had seen a medical provider in the past 6 months. Sixty-two percent of the male-to-female and 55% of the female-to-male transgender persons were depressed, 32% of each population had attempted suicide. Conclusions. High HIV prevalence suggests an urgent need for risk reduction interventions for male-to-female transgender persons. Recent contact with medical providers was observed, suggesting that medical providers could provide an important link to needed prevention, health, and social sex-vices.
引用
收藏
页码:915 / 921
页数:7
相关论文
共 46 条
[31]  
Sykes D., 1999, CALIF HIV AIDS UPDAT, V12, P80
[32]  
TIRELLI U, 1991, J ACQ IMMUN DEF SYND, V4, P302
[33]  
TIRELLI U, 1988, J ACQ IMMUN DEF SYND, V1, P414
[34]  
TIRELLI U, 1989, AIDS, V3, P547
[35]  
VALENTA LJ, 1992, J NATL MED ASSOC, V84, P241
[36]   Mortality and morbidity in transsexual subjects treated with cross-sex hormones [J].
vanKesteren, PJM ;
Asscheman, H ;
Megens, JAJ ;
Gooren, LJG .
CLINICAL ENDOCRINOLOGY, 1997, 47 (03) :337-342
[37]   Antecedents and consequences of victimization of lesbian, gay, and bisexual young people: A structural model comparing rural university and urban samples [J].
Waldo, CR ;
Hesson-McInnis, MS ;
D'Augelli, AR .
AMERICAN JOURNAL OF COMMUNITY PSYCHOLOGY, 1998, 26 (02) :307-334
[38]  
WATTERS JK, 1994, J ACQ IMMUN DEF SYND, V7, P1276
[39]   SYRINGE AND NEEDLE EXCHANGE AS HIV AIDS-PREVENTION FOR INJECTION-DRUG USERS [J].
WATTERS, JK ;
ESTILO, MJ ;
CLARK, GL ;
LORVICK, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (02) :115-120
[40]   TARGETED SAMPLING - OPTIONS FOR THE STUDY OF HIDDEN POPULATIONS [J].
WATTERS, JK ;
BIERNACKI, P .
SOCIAL PROBLEMS, 1989, 36 (04) :416-430